Impact of Lymphadenectomy on the Oncologic Outcome of Patients with Adrenocortical Carcinoma-A Systematic Review and Meta-Analysis.
LND
LNE
adrenal cancer
adrenocortical carcinoma
lymph node dissection
lymphadenectomy
meta-analysis
review
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Jan 2022
07 Jan 2022
Historique:
received:
26
11
2021
revised:
20
12
2021
accepted:
04
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
22
1
2022
Statut:
epublish
Résumé
(1) Background: Locoregional lymphadenectomy (LND) in adrenocortical carcinoma (ACC) may impact oncological outcome, but the findings from individual studies are conflicting. The aim of this systematic review and meta-analysis was to determine the oncological value of LND in ACC by summarizing the available literature. (2) Methods: A systematic search on studies published until December 2020 was performed according to the PRISMA statement. The primary outcome was the impact of lymphadenectomy on overall survival (OS). Two separate meta-analyses were performed for studies including patients with localized ACC (stage I-III) and those including all tumor stages (I-IV). Secondary endpoints included postoperative mortality and length of hospital stay (LOS). (3) Results: 11 publications were identified for inclusion. All studies were retrospective studies, published between 2001-2020, and 5 were included in the meta-analysis. Three studies (
Identifiants
pubmed: 35053453
pii: cancers14020291
doi: 10.3390/cancers14020291
pmc: PMC8774191
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cancer. 2008 Dec 1;113(11):3130-6
pubmed: 18973179
Lancet. 1993 Feb 20;341(8843):457-60
pubmed: 8094488
Horm Metab Res. 2015 Oct;47(11):820-5
pubmed: 25938888
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Surgery. 1995 Dec;118(6):1090-8
pubmed: 7491528
Am Surg. 2013 Oct;79(10):1115-8
pubmed: 24160811
Eur J Endocrinol. 2018 Oct 01;179(4):G1-G46
pubmed: 30299884
World J Surg. 2001 Jul;25(7):914-26
pubmed: 11572033
World J Surg. 2016 Mar;40(3):697-705
pubmed: 26510563
Anticancer Res. 2015 Oct;35(10):5575-9
pubmed: 26408728
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3566-3573
pubmed: 29982685
Asian Pac J Cancer Prev. ;18(10):2817-2823
pubmed: 29072424
J Endocrinol Invest. 2016 Jan;39(1):103-21
pubmed: 26165270
Langenbecks Arch Surg. 2019 Jun;404(4):385-401
pubmed: 30937523
Endocr Pract. 2020 Nov;26(11):1366-1383
pubmed: 33875173
Ann Surg Oncol. 2018 Aug;25(8):2308-2315
pubmed: 29868977
Ann Surg Oncol. 2017 Nov;24(12):3617-3623
pubmed: 28895102
Open Med. 2009;3(3):e123-30
pubmed: 21603045
J Surg Oncol. 2020 Nov;122(6):1152-1162
pubmed: 32705677
Eur Urol. 2014 Apr;65(4):832-8
pubmed: 24268504
J Clin Endocrinol Metab. 2010 Nov;95(11):4925-32
pubmed: 20668036
Arch Surg. 2001 May;136(5):543-9
pubmed: 11343545
World J Surg. 2001 Jul;25(7):891-7
pubmed: 11572030
Endocr Relat Cancer. 2005 Sep;12(3):667-80
pubmed: 16172199
Endocr Rev. 2014 Apr;35(2):282-326
pubmed: 24423978
Br J Surg. 2017 Mar;104(4):358-376
pubmed: 28199015
Cancer. 2009 Jan 15;115(2):243-50
pubmed: 19025987
Ann Surg Oncol. 2016 Dec;23(Suppl 5):708-713
pubmed: 27590329
J Urol. 1978 Dec;120(6):660-5
pubmed: 731800
Ann Surg Oncol. 2019 Feb;26(2):531-538
pubmed: 30443830
Ann Surg. 2012 Feb;255(2):363-9
pubmed: 22143204
Ann Oncol. 2020 Nov;31(11):1476-1490
pubmed: 32861807
J Clin Endocrinol Metab. 2013 Dec;98(12):4551-64
pubmed: 24081734
Ann Surg Oncol. 1999 Dec;6(8):719-26
pubmed: 10622498
Prog Urol. 2018 Nov;28 Suppl 1:R177-R195
pubmed: 31610872
N Engl J Med. 2012 Jun 7;366(23):2189-97
pubmed: 22551107